BGIM
HIMS icon

Boussard & Gavaudan Investment Management’s Hims & Hers Health HIMS Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400,000
Closed -$4.69M – 70
2020
Q3 		$4.69M Hold
400,000
– – 0.6% 26
2020
Q2 		$4.08K Hold
400,000
– – 0.77% 19
2020
Q1 		$3.99M Buy
+400,000
New +$3.97M 0.87% 18

Other funds holding HIMS

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Boussard & Gavaudan Investment Management's HIMS Position: Q4 2020 in Review

Boussard & Gavaudan Investment Management sold out of Hims & Hers Health (HIMS) in Q4 2020, closing a stake of 400,000 shares — an estimated $4.69M sold.

Boussard & Gavaudan Investment Management first reported a position in HIMS in Q1 2020 and held it in 3 quarters. The position peaked at $4.69M in Q3 2020. 42 funds tracked by Wall St. Rank hold HIMS as of Q4 2020.

  • Boussard & Gavaudan Investment Management reported no remaining Hims & Hers Health position as of Q4 2020 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 400,000 Hims & Hers Health shares in Q4 2020, an estimated $4.69M.
  • Boussard & Gavaudan Investment Management first reported a position in Hims & Hers Health in Q1 2020 and held it in 3 quarters.
  • Boussard & Gavaudan Investment Management's Hims & Hers Health position peaked at $4.69M in Q3 2020.
  • 42 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2020.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2020, filed 10 Feb 2021.